• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Issues that matter
    • COVID-19 in India
    • Inadequate safe drinking water
    • Poor sanitation
    • Environmental health
    • Infectious disease
      • Hepatitis C
    • Noncommunicable Diseases (NCDs)
    • Malnutrition
    • High infant mortality
    • Mental health
    • Sex and gender discrimination
  • Special Focus
    • Interviews
      • Exclusive Interviews
      • Readers Interviews
    • Vaccine Hesitancy
  • News
  • PandemiCast
  • Partner’s Press Office

Health Issues India

Health issues in India

  • Home
  • About Us
  • Editorial Team
  • Subscribe
  • Contribute
  • Sponsor
  • Contact Us
You are here: Home / Featured / State of the art genomics lab to be built in Allahabad

State of the art genomics lab to be built in Allahabad

May 10, 2019 By Nicholas Parry Leave a Comment

An Rs 20 crore project has been commissioned by the Union Ministry of Science and Technology to establish a state-of-the-art genomics facility at Allahabad University.

Allahabad University. Attribution: Wikimedia commons PTWO

Professor Rizvi of the Department of Biochemistry has been named as the principal investigator of the facility. The professor elaborated on the potential for the facility, stating “the technology is now being increasingly used to find answers to many human diseases, increasing crop output, pharmacogenetics and targeted therapy, prenatal diagnosis and testing, personalized medicine, etc,”

Genomics has a huge potential to improve medical capacities in India, although it suffers the drawback of being considerably expensive in its current state. Genome analysis, for example, can uncover genetic risks of a number of conditions such as heart disease or diabetes. The costs of the analysis, however, can be in excess of a thousand USD, and so is priced out of reach of many within India.

Work has already begun at Allahabad University for site preparation in the Department of Biochemistry. The National Genomics Core at Allahabad University is expected to start its work within three months. The core will also cater to the needs of institutions from other parts of northern India, added Professor Rizvi.

Collaboration between multiple universities at the new genomics facility could greatly enhance the research capabilities of the region. Of particular note is the capacity to perform genome-wide association studies (GWAS).

GWAS involve studying the genomes of vast swathes of the population — the greater the number the higher the power of the study — in order to find genes associated with specific conditions. Successes have been made in this regard in uncovering several genes common among the Indian population that genetically predispose individuals to developing diabetes.

The unique, diabetes-related genes demonstrate the potential for GWAS. However, India is currently highly underrepresented in GWAS studies. Of the global gene sequence databanks, Indian genomes only represent 0.2 percent. The current majority of genomes — around 96 percent — are of European ancestry.

By ignoring Indian genomes and the considerable range of diversity across the Indian population, many genes – both positive and negative – are being left out of these studies. The new genomics facility opens up the possibility to discover more about the genetic makeup of the Indian population. Potentially, if relevant risks are discovered, this could guide future health policy.

Filed Under: Featured, Medicine and Research, News, Science and Technology

About Nicholas Parry

Nicholas Parry has a Bachelor of Science in genetics from the University of Sheffield and a Master of Research in neuroscience from the University of Nottingham. He has been a featured writer for Health Issues since 2016. He is based in South Wales.

Reader Interactions

Leave a Reply Cancel reply

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Primary Sidebar

Articles

  • Renewed fears of a bird flu pandemic; The latest health stories from around the world
  • More oversight needed for “gain of function” research says expert panel; The latest health stories from around the world
  • Marion Biotech to be investigated by Indian drug regulator
  • Sesame to be added to list of major food allergens
  • Approval of Alzheimer’s drug “rife with irregularities”

Footer

Archives

Issues that matter

  • Environmental health
  • Inadequate safe drinking water
  • Poor sanitation
  • Infectious disease
  • Noncommunicable Diseases (NCDs)
  • Malnutrition
  • High infant mortality

Categories

Copyright © 2023 · News Pro On Genesis Framework · WordPress · Log in

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent.
Cookie settingsACCEPTACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.